STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock options granted			315,881,000
Share-based payment arrangement, nonvested award, cost not yet recognized, amount	$ 1,144,000		$ 1,144,000
Recognized over remaining weighted average period			2 years 10 months 24 days
Restricted Stock Awards [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based payment arrangement, nonvested award, cost not yet recognized, amount	$ 600,000		$ 600,000
Recognized over remaining weighted average period			2 years 10 months 24 days
Number of shares granted	0		447,543
Weighted average grant date fair value per share	$ 1.03		$ 1.03
Total fair value grant	$ 500,000		$ 500,000
Share-based compensation srrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, outstanding	900,000		900,000
Share-based payment arrangement, expense	$ 100,000	$ 0	$ 200,000	$ 100,000
Omnibus Equity Incentive Plan 2021 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock options granted	0		315,881
Weighted average grant date fair values	$ 1.11		$ 1.11
Omnibus Equity Incentive Plan 2021 [Member] | Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based payment arrangement, nonvested award, cost not yet recognized, amount	$ 500,000		$ 500,000
Recognized over remaining weighted average period			3 years 3 months 18 days
Weighted average remaining contractual life of outstanding stock options			9 years 1 month 6 days